Business Description
Sam-A-Pharm Co Ltd
ISIN : KR7009300005
Compare
Compare
Traded in other countries / regions
009300.Korea IPO Date
2000-07-19Description
Sam-A-Pharm Co Ltd is a South Korea based company engages in the manufacturing of pharmaceutical products. Its products include medicines for cold and fever, inflammatory, allergy, nutrition, and respiratory and digestive systems.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.73 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.31 | |||||
| Interest Coverage | 214.35 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.37 | |||||
| Beneish M-Score | -2.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.5 | |||||
| 3-Year EBITDA Growth Rate | 80 | |||||
| 3-Year EPS without NRI Growth Rate | 385.8 | |||||
| 3-Year FCF Growth Rate | 25.3 | |||||
| 3-Year Book Growth Rate | 6.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.33 | |||||
| 9-Day RSI | 47.71 | |||||
| 14-Day RSI | 43.86 | |||||
| 6-1 Month Momentum % | -24.58 | |||||
| 12-1 Month Momentum % | 5.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.75 | |||||
| Quick Ratio | 4.17 | |||||
| Cash Ratio | 3.16 | |||||
| Days Inventory | 135.34 | |||||
| Days Sales Outstanding | 82.3 | |||||
| Days Payable | 56.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.32 | |||||
| Dividend Payout Ratio | 0.2 | |||||
| 3-Year Dividend Growth Rate | 35.7 | |||||
| Forward Dividend Yield % | 4.32 | |||||
| 5-Year Yield-on-Cost % | 10.44 | |||||
| Shareholder Yield % | -3.27 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.92 | |||||
| Operating Margin % | 24.87 | |||||
| Net Margin % | 22.46 | |||||
| FCF Margin % | 25.36 | |||||
| ROE % | 11.07 | |||||
| ROA % | 9.61 | |||||
| ROIC % | 13.02 | |||||
| ROC (Joel Greenblatt) % | 53.78 | |||||
| ROCE % | 14.23 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 4.63 | |||||
| PE Ratio without NRI | 4.63 | |||||
| Price-to-Owner-Earnings | 2.93 | |||||
| PEG Ratio | 0.24 | |||||
| PS Ratio | 1.04 | |||||
| PB Ratio | 0.5 | |||||
| Price-to-Tangible-Book | 0.5 | |||||
| Price-to-Free-Cash-Flow | 4.09 | |||||
| Price-to-Operating-Cash-Flow | 3.24 | |||||
| EV-to-EBIT | 1.43 | |||||
| EV-to-EBITDA | 1.24 | |||||
| EV-to-Revenue | 0.42 | |||||
| EV-to-FCF | 1.67 | |||||
| Price-to-Projected-FCF | 0.27 | |||||
| Price-to-Median-PS-Value | 0.65 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.18 | |||||
| Price-to-Graham-Number | 0.32 | |||||
| Price-to-Net-Current-Asset-Value | 1.34 | |||||
| Price-to-Net-Cash | 2.52 | |||||
| Earnings Yield (Greenblatt) % | 70.22 | |||||
| FCF Yield % | 24.43 | |||||
| Forward Rate of Return (Yacktman) % | 34.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sam-A-Pharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 101,393.019 | ||
| EPS (TTM) (â‚©) | 3731 | ||
| Beta | 0.81 | ||
| Volatility % | 83.83 | ||
| 14-Day RSI | 43.86 | ||
| 14-Day ATR (â‚©) | 556.616685 | ||
| 20-Day SMA (â‚©) | 17097 | ||
| 12-1 Month Momentum % | 5.05 | ||
| 52-Week Range (â‚©) | 15520 - 37950 | ||
| Shares Outstanding (Mil) | 6.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sam-A-Pharm Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sam-A-Pharm Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sam-A-Pharm Co Ltd Frequently Asked Questions
What is Sam-A-Pharm Co Ltd(XKRX:009300)'s stock price today?
The current price of XKRX:009300 is â‚©17250.00. The 52 week high of XKRX:009300 is â‚©37950.00 and 52 week low is â‚©15520.00.
When is next earnings date of Sam-A-Pharm Co Ltd(XKRX:009300)?
The next earnings date of Sam-A-Pharm Co Ltd(XKRX:009300) is .
Does Sam-A-Pharm Co Ltd(XKRX:009300) pay dividends? If so, how much?
The Dividend Yield %  of Sam-A-Pharm Co Ltd(XKRX:009300) is 4.32% (As of Today), Highest Dividend Payout Ratio of Sam-A-Pharm Co Ltd(XKRX:009300) was 10.2. The lowest was 0.15. And the median was 0.19. The  Forward Dividend Yield % of Sam-A-Pharm Co Ltd(XKRX:009300) is 4.32%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers